Foresight Group LTD Liability Partnership Astrazeneca PLC Transaction History
Foresight Group LTD Liability Partnership
- $705 Billion
- Q2 2025
A detailed history of Foresight Group LTD Liability Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Foresight Group LTD Liability Partnership holds 195,892 shares of AZN stock, worth $16.6 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
195,892
Previous 217,824
10.07%
Holding current value
$16.6 Million
Previous $31.6 Billion
14.14%
% of portfolio
3.85%
Previous 4.46%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,416Shares Held
497MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.65 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.63 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...